167 related articles for article (PubMed ID: 33882762)
1. Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience.
Prinja S; Jyani G; Gupta N; Rajsekar K
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):859-868. PubMed ID: 33882762
[TBL] [Abstract][Full Text] [Related]
2. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
3. Addressing the need for economic evaluation of cardiovascular medical devices in India.
Masurkar PP
Curr Probl Cardiol; 2024 Aug; 49(8):102677. PubMed ID: 38795804
[TBL] [Abstract][Full Text] [Related]
4. Health technology assessment of medical devices: a survey of non-European union agencies.
Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
[TBL] [Abstract][Full Text] [Related]
5. Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review.
Farah L; Borget I; Martelli N; Vallee A
J Med Internet Res; 2024 May; 26():e51514. PubMed ID: 38739911
[TBL] [Abstract][Full Text] [Related]
6. The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.
Grimm SE; Strong M; Brennan A; Wailoo AJ
Pharmacoeconomics; 2017 Dec; 35(12):1287-1296. PubMed ID: 28849538
[TBL] [Abstract][Full Text] [Related]
7. HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.
Polisena J; Castaldo R; Ciani O; Federici C; Borsci S; Ritrovato M; Clark D; Pecchia L
Int J Technol Assess Health Care; 2018 Jan; 34(3):276-289. PubMed ID: 29909792
[TBL] [Abstract][Full Text] [Related]
8. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
[TBL] [Abstract][Full Text] [Related]
9. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
Shiroiwa T; Fukuda T; Ikeda S; Takura T
Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
[TBL] [Abstract][Full Text] [Related]
10. The Challenges in Conducting Economic Evaluations for Rehabilitation Technologies.
Chan BC
Top Spinal Cord Inj Rehabil; 2023; 29(Suppl):44-52. PubMed ID: 38174139
[TBL] [Abstract][Full Text] [Related]
11. Impact assessment of Iran's health technology assessment programme.
Yazdizadeh B; Mohtasham F; Velayati A
Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
[TBL] [Abstract][Full Text] [Related]
12. A review of the economic tools for assessing new medical devices.
Craig JA; Carr L; Hutton J; Glanville J; Iglesias CP; Sims AJ
Appl Health Econ Health Policy; 2015 Feb; 13(1):15-27. PubMed ID: 25139635
[TBL] [Abstract][Full Text] [Related]
13. Health technology assessment for medical devices in Europe. What must be considered.
Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
[TBL] [Abstract][Full Text] [Related]
14. Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report.
Drummond MF; Augustovski F; Bhattacharyya D; Campbell J; Chaiyakanapruk N; Chen Y; Galindo-Suarez RM; Guerino J; Mejía A; Mujoomdar M; Ollendorf D; Ronquest N; Torbica A; Tsiao E; Watkins J; Yeung K;
Value Health; 2022 Aug; 25(8):1257-1267. PubMed ID: 35931428
[TBL] [Abstract][Full Text] [Related]
15. HTA of medical devices: Challenges and ideas for the future from a European perspective.
Fuchs S; Olberg B; Panteli D; Perleth M; Busse R
Health Policy; 2017 Mar; 121(3):215-229. PubMed ID: 27751533
[TBL] [Abstract][Full Text] [Related]
16. Health economics and health technology assessment: perspectives from Australia and New Zealand.
Streat S; Munn S
Crit Care Clin; 2012 Jan; 28(1):125-33, vii. PubMed ID: 22123104
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the Assessment of Medical Devices: The MedtecHTA Project.
Tarricone R; Torbica A; Drummond M
Health Econ; 2017 Feb; 26 Suppl 1():5-12. PubMed ID: 28139084
[TBL] [Abstract][Full Text] [Related]
18. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany.
Kieslich K
Health Econ Policy Law; 2020 Jul; 15(3):370-385. PubMed ID: 30975237
[TBL] [Abstract][Full Text] [Related]
19. Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices.
Heupink LF; Peacocke EF; Sæterdal I; Chola L; Frønsdal K
Int J Technol Assess Health Care; 2022 Nov; 38(1):e78. PubMed ID: 36321421
[TBL] [Abstract][Full Text] [Related]
20. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
Brettschneider C; Lühmann D; Raspe H
GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
